Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bio-Techne (TECH)
:TECH
Holding TECH?
Track your performance easily
Earnings Data
Report Date
Feb 04, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.39Last Year’s EPS
0.4Same Quarter Last Year
Moderate Buy
Based on 6 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Oct 30, 2018
|% Change Since: 5.76%
|Next Earnings Date:Aug 07, 2018
Earnings Call Sentiment|Positive
Bio-Techne's earnings call for Q1 2025 highlighted strong growth in diagnostics, spatial biology, and cell and gene therapy businesses. Despite challenges in China and operating margin pressures, the overall performance was aligned with expectations, showcasing stability and positive momentum across key growth areas.Company Guidance
In the Q1 2025 earnings call for Bio-Techne, the company reported a 4% year-over-year organic revenue growth, driven by strong performance across its growth pillars, particularly in the molecular diagnostics and spatial biology platforms. The Diagnostics and Spatial Biology segment saw a 14% increase in both reported and organic growth, while the Protein Sciences segment experienced 1% organic growth, despite challenges in the Chinese market. The company's adjusted EPS was $0.42, with a revenue of $289.5 million for the quarter. The team highlighted significant progress in their cell and gene therapy business, where GMP reagent product lines grew by over 60%. With strategic cost containment and productivity initiatives, Bio-Techne maintained its peer-leading operating margin profile, with an adjusted operating margin of 29%. The company remains confident in its strategic investments and anticipates a gradual recovery in the life sciences markets, projecting mid-single-digit growth in the first half of fiscal 2025.Organic Revenue Growth
Bio-Techne reported a 4% year-over-year organic revenue growth for Q1 2025, driven by strong performance in the molecular diagnostics, spatial biology platforms, and proteomic analysis franchise.
Strong Performance in Diagnostics and Spatial Biology
The Diagnostics and Spatial Biology segment grew 14% year-over-year, supported by the ExoDx prostate test and the COMET platform.
Cell and Gene Therapy Business Growth
The GMP reagent product lines increased over 60% in Q1 with robust growth in both large customers and smaller biotech companies.
Wilson Wolf Joint Venture
Bio-Techne's 20% ownership in Wilson Wolf, which grew over 30%, is contributing positively to the company's financials.
Proteomic Analytical Instrumentation Growth
Mid-single-digit growth in the proteomic analytical instrumentation division, with the introduction of the LEO system increasing customer interest.
ESG Initiatives Progress
Bio-Techne made significant progress in ESG initiatives, including commitments to reduce Scope 1, 2, and 3 greenhouse gas emissions.
---
TECH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
TECH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 30, 2024 | $70.66 | $75.94 | +7.47% |
| Aug 07, 2024 | $78.25 | $70.81 | -9.51% |
| May 01, 2024 | $63.01 | $73.23 | +16.22% |
| Feb 01, 2024 | $70.02 | $68.24 | -2.54% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Bio-Techne (TECH) report earnings?
Bio-Techne (TECH) is schdueled to report earning on Feb 04, 2025, TBA Not Confirmed.
What is Bio-Techne (TECH) earnings time?
Bio-Techne (TECH) earnings time is at Feb 04, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TECH EPS forecast?
TECH EPS forecast for the fiscal quarter 2025 (Q2) is 0.39.
---